Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Velleca Mark A. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2023 4 Velleca Mark A. (Director) has filed a Form 4 on G1 Therapeutics, Inc.
Txns: Sold 57,286 shares @ $1.9986, valued at $114.5k
Sold 2,714 shares @ $2.02, valued at $5.5k
Exercised 57,286 options to buy @ $0.39, valued at $22.3k
Exercised 2,714 options to buy @ $0.3, valued at $814.2
06/16/2023 4 Velleca Mark A. (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.
Txns: Granted 8,929 shares @ $2.1, valued at $18.8k
05/17/2023 4 Velleca Mark A. (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.
Txns: Granted 16,500 options to buy @ $1.82, valued at $30k
03/20/2023 4 Velleca Mark A. (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.
Txns: Granted 11,228 shares @ $1.67, valued at $18.8k
12/19/2022 4 Velleca Mark A. (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.
Txns: Granted 8,424 shares @ $1.5, valued at $12.6k
10/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/22/2022 4 Velleca Mark A. (Director) has filed a Form 4 on G1 Therapeutics, Inc.
Txns: Sold 20,000 shares @ $13.5022, valued at $270k
Exercised 20,000 options to buy @ $0.39, valued at $7.8k
09/19/2022 4 Velleca Mark A. (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.
Txns: Granted 4,294 shares @ $2.62, valued at $11.3k
08/18/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/18/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/08/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/10/2021 4 Velleca Mark A. (Director) has filed a Form 4 on G1 Therapeutics, Inc.
Txns: Exercised 40,000 options to buy @ $0.39, valued at $15.6k
08/11/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/25/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/13/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/18/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/21/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/17/2020 4 Velleca Mark A. (President and CEO) has filed a Form 4 on G1 Therapeutics, Inc.
Txns: Sold 10,000 shares @ $19.4297, valued at $194.3k
Sold 10,000 shares @ $19.2021, valued at $192k
Sold 10,000 shares @ $19.9668, valued at $199.7k
Exercised 10,000 options to buy @ $3.72, valued at $37.2k
Exercised 10,000 options to buy @ $3.72, valued at $37.2k
Exercised 10,000 options to buy @ $3.72, valued at $37.2k
03/16/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/07/2020 4 Velleca Mark A. (President and CEO) has filed a Form 4 on G1 Therapeutics, Inc.
Txns: Granted 220,000 options to buy @ $21.08, valued at $4.6M
01/24/2020 4 Velleca Mark A. (President and CEO) has filed a Form 4 on G1 Therapeutics, Inc.
Txns: Exercised 6,000 options to buy @ $0.39, valued at $2.3k
01/17/2019 4 Velleca Mark A. (President and CEO) has filed a Form 4 on G1 Therapeutics, Inc.
Txns: Exercised 9,000 options to buy @ $0.39, valued at $3.5k
01/02/2019 4 Velleca Mark A. (President and CEO) has filed a Form 4 on G1 Therapeutics, Inc.
Txns: Granted 225,000 options to buy @ $19.56, valued at $4.4M
11/16/2018 4 Velleca Mark A. (President and CEO) has filed a Form 4 on G1 Therapeutics, Inc.
Txns: Sold 4,985 shares @ $39.8399, valued at $198.6k
Sold 15 shares @ $40.59, valued at $608.9
Exercised 5,000 options to buy @ $3.72, valued at $18.6k
10/15/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/19/2018 4 Velleca Mark A. (President and CEO) has filed a Form 4 on G1 Therapeutics, Inc.
Txns: Sold 2,835 shares @ $65.7376, valued at $186.4k
Sold 1,865 shares @ $66.9158, valued at $124.8k
Sold 300 shares @ $67.95, valued at $20.4k
Exercised 5,000 options to buy @ $3.72, valued at $18.6k
08/17/2018 4 Velleca Mark A. (President and CEO) has filed a Form 4 on G1 Therapeutics, Inc.
Txns: Sold 2,699 shares @ $55.3287, valued at $149.3k
Sold 2,301 shares @ $56.5171, valued at $130k
Exercised 5,000 options to buy @ $3.72, valued at $18.6k
07/17/2018 4 Velleca Mark A. (President and CEO) has filed a Form 4 on G1 Therapeutics, Inc.
Txns: Gifted 1,000 shares @ $0
Sold 3,800 shares @ $41.8574, valued at $159.1k
Sold 1,200 shares @ $42.7125, valued at $51.3k
Exercised 5,000 options to buy @ $3.72, valued at $18.6k
05/31/2018 4 Velleca Mark A. (President and CEO) has filed a Form 4 on G1 Therapeutics, Inc.
Txns: Exercised 10,000 options to buy @ $0.39, valued at $3.9k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy